Dates From Monday to Friday October 2nd-6th Place Institut Pasteur of Morocco, Casablanca TOPICS

Similar documents
Antibody Discovery at Evotec

Nano Proteo Genomics Summer Course 2017

List of E-journals Subscribed for the year 2016 (January to December) Pharmacy Faculty Sl. No.

EUROPEAN COMMISSION FOR DEMOCRACY THROUGH LAW (VENICE COMMISSION) in cooperation with

The response of research: from the field to the lab. K. Victoir PhD

FIRST YEAR PHARM. D. Know about the theory and their application in pharmacy PDM107 Remedial Mathematics

Diploma (Base Course) in Medicines Development

Research Article. Assessment of preclinical efficacy of antivenoms produced in rabbit by immunological methods and neutralization assays

The Integrated Biomedical Sciences Graduate Program

FCT PhD Programme Medicines and Pharmaceutical Innovation (i3du)

Advancing Life Sciences

Proteomics and Cancer

Research Article. Optimization and validation of rapid and simple method for determination of Isoniazid and Pyrazinamide in plasma by HPLC-UV

Duncan Holmes European Head Discovery Partnerships with Academia GlaxoSmithKline

Our website:

MASTER IN PHARMACEUTICAL SCIENCES (Thesis Track)

How Targets Are Chosen. Chris Wayman 12 th April 2012

Genomics Research Center: Current Status & Future Development

SSPPS STRATEGIC PLAN. Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice. April 30, Overview

Speakers Title & Biography

Organizing committee at imed.ulisboa/ffulisboa Joao Goncalves (Coordinator) and Paula Brito.

The Institute of Microbiology of the Czech Academy of Sciences is looking for. four POSTDOCTORAL FELLOW positions in the fields of:

Peptide libraries: applications, design options and considerations. Laura Geuss, PhD May 5, 2015, 2:00-3:00 pm EST

APPLIED BLUE BIOTECHNOLOGY MASTER

Post-Baccalaureate Program in Pharmaceutical Science. Accelerate your career

THE 6 th OIE STRATEGIC PLAN Period

FCT PhD Programme Medicines and Pharmaceutical Innovation (i3du)

SPONSORSHIP OPPORTUNITIES

ATIP Avenir Program 2018 Young group leader

BIOLOGY AND MEDICINE OF MOLECULES

Lecture 23: Clinical and Biomedical Applications of Proteomics; Proteomics Industry

4 th ESPT SUMMER SCHOOL

Week 1: Discovery Biology Basic knowledge and tools used in Research and Development

Co sourcing -> Shared sourcing

MODULE 11 Pharmacovigilance March 2017 POST-GRADUATE PROGRAMME IN PHARMACEUTICAL MEDICINE & MEDICINES DEVELOPMENT SCIENCES

Applied Blue Biotechnology Master

SPEED UP YOUR TIME TO MARKET

From Discovery to Development of new Drugs. and pitfalls along the way. by Kim Dekermendjian, PhD in Medicine BD & Key Account manager

CENTER FOR BIOTECHNOLOGY

What IMI means for POLAND

Discovery of Orally Bioavailable Small Molecules for Inhibition of Complement C5

Drug Targets - an overview of historical success and protein kinase inhibitors - successes and attrition. John P. Overington

11/23/2013. However, this medical problem has been neglected..

what you need to know

Protein & Biomedical Engineering

4 th ESPT SUMMER SCHOOL

Capabilities & Services

Course Agenda. Day One

Preliminary Course Program

Sharing Knowledge and Experience on negotiating licensing agreements

Introduction to Drug Development

METABOLOMICS: OPPORTUNITIES AND CHALLENGES

Glycobiology Asia 2019

REIMAGINING DRUG DEVELOPMENT:

11/22/13. Proteomics, functional genomics, and systems biology. Biosciences 741: Genomics Fall, 2013 Week 11

Biomedical Sciences Graduate Program

The 13th ICDRA (16-19 September) Regulatory Approaches to proving Interchangeability. WHO Biowaiver Guideline in Regulatory Practice

University of Pennsylvania Perelman School of Medicine High Throughput Screening Core

IMMUNOTHERAPY 2008: IMPLEMENTING COMBINATIONS

Computational methods in drug discovery

E&T objectives in evolving pharma business models. Magda Chlebus Director Science Policy Brussels, 2 March 2015

Sangamo Therapeutics Announces Presentations at 2017 Annual meeting of the American Society of Gene & Cell Therapy

Defining the Expertise for the 21 st Century Neuroscience Workforce. James E. Barrett, Ph.D. Professor and Chair

Introduction to Drug Design and Discovery

COURSES IN BIOLOGICAL SCIENCE. Undergraduate Courses Postgraduate Courses

Compound Re-Profiling. Dr Robert Scoffin CEO, Cresset

Strategic priority for AMR

Excipient Albumin CSL Behring Human Serum Albumin

Eleventh Annual Chapel Hill Pharmaceutical Sciences Conference. Pharmacy in the Era of Precision Medicine: From Discovery to Implementation

Recent years have witnessed an expansion in the disciplines encompassing drug

Biology Registration Newsletter for Fall 2018 Courses

INTERNATIONAL PROTEOMICS & METABOLOMICS CONFERENCE AND ADVANCED PROTEOMIC SCHOOL NOVARA, JUNE 2018

Update on the new immunogenicity guideline in the EU

TARGET VALIDATION. Maaike Everts, PhD (with slides from Dr. Suto)

The Role of University in Clinical Research Training. Jorge Kalil MD, PhD Professor of Medicine University of São Paulo, Brazil

From Gene-Targeted Tests to Genome-Wide Data in Cancer Genetics: A Paradigm for the Development of Personalised Genomic Medicine?

NIAID and Global Health Research Resources for Tuberculosis

Integrated Protection in Oak Forests. Working Group

Agreed with W. Cornell Graduate Program and Tri-I

Predoc Course 2013 Disease Mechanisms Module (16-18 December 2013)

B2B Participation

Chemistry in Drug Discovery & Designing

Biosimilar Monoclonal Antibodies: Registration Requirements. Henry M. J. Leng

National Academic Reference Standards (NARS) Pharmacy. January st Edition

Bayer Pharma s High Tech Platform integrates technology experts worldwide establishing one of the leading drug discovery research platforms

B2B Participation

About OMICS Group Conferences

We welcome the participation of external academic and scientific community members. Registration is free but mandatory.

Is the grass greener on the other side.? Academia to Industry Stephen B. Helliwell

Intergrative Omics via Mass Spectrometry: A workshop on Integrated Biology

Towards unbiased biomarker discovery

Programme. Tunis, March 2016 BUILDIN. "Better regulation for better lives. 9 th annual meeting of the MENA-OECD Working Group IV

Malaria Research Capability Strengthening in Africa

Trend in diagnostic biochip. Eiichiro Ichiishi, M.D., Ph.D. Department of Internal Medicine International University of Health and Welfare Hospital

Diploma Course on Research & Development of Products to Meet Public Health Needs

Innovative Medicines Initiative (IMI) and other Public Private Partnerships: Educational Ambitions

Multiple Myeloma Training for Physicians 2018

GUIDANCE ON THE EVALUATION OF NON ACCREDITED QUALIFICATIONS

The Power to Cure: Therapeutic Innovation in Academia

Transcription:

Dates From Monday to Friday October 2nd-6th 2017 Place Institut Pasteur of Morocco, Casablanca TOPICS o Biology & Systematics o Epidemiological Aspects & Management of Envenomation o Venoms, Composition and Mode of Action o Immunotherapy (Classic and Innovative) o Venomics & Antivenomics o Therapeutic Potential of Venom Bioactive Peptides 1

LIST OF SPEAKERS Name Email Institute Country Balkiss BOUHOUALA balkiss.bouhaouala@gmail.com Institut Pasteur of Tunis Tunisia Dominique KOUA dominique.koua@atheris.com National Polytechnical Institute of Yamoussoukro and University of Bern Ivory Coast and Switzerland Fabien TAEIB fabien.taieb@pasteur.fr Institut Pasteur of Paris France Fatima LARABA-DJEBARI flaraba@hotmail.com University of Science and Technology, Houari Boumédiène Algiers, Algeria Algeria Rym BEN KHALIFA rym.benkhalifa@pasteur.tn Institut Pasteur of Tunis Tunisia - S jpaniagua@bluewin.ch International consultant, expert in biological products development, Lausanne, Switzerland Switzerland Julia CHAMOT-ROOKE julia.chamot-rooke@pasteur.fr Institut Pasteur of Paris France Mohammed FEKHAOUI fekhaoui@israbat.ac.ma Scientific Institute of Rabat Morocco Juan J. CALVETE Walter GARCIA UBBELOHDE jcalvete@ibv.csic.es wgarcia@silanes.com.mx Laboratorio de Venómica Estructural y Funcional, Instituto de Biomedicina de Valencia Deputy Director Medical Research Laboratorios Silane, Mexico city Spain Mexico Naoual OUKKACHE Oukkache.naoual@gmail.com Institut Pasteur of Morocco, Casablanca Morocco Oulaid TOULOUN o_touloun@yahoo.fr University of Science, Marrakech Morocco Fatima CHGOURY fchgoury@gmail.com Institut Pasteur of Morocco, Casablanca Morocco Rachid ELJAOUDI Rachida SOULAYMANI- BENCHEINCH eljaoudi_rachid@yahoo.fr rsoulaymani@gmail.com Faculty of Medicine and Pharmacy of Rabat Centre Anti-Poison et de Pharmacovigilance du Maroc Morocco Morocco Reto STÖCKLIN reto.stocklin@atheris.com Atheris SA, Geneva Switzerland Roland STOCKMANN roland.stockmann@wanadoo.fr Paris VI University France Vincent VAGNIERE vva1@rocketmail.com Independent consultant, expert in breeding and milking, Lausanne Switzerland 2

DAY 1 9h00 9h15 9h35 TENTATIVE DETAILED PROGRAM Registration & Welcome Opening Ceremony & Course Intro Oral presentation of one-minute of the Research Projects by each student Session 1: Biology & Systematics 11h30 12h30 Biology & systematics of the snake Pr Mohammed FEKHAOUI Scientific Institute of Rabat Geographical distribution of snakes in Morocco Pr Mohammed FEKHAOUI Scientific Institute of Rabat The reproduction of the scorpion - Climate change impact Pr Roland STOCKMANN PARIS VI University Biology & systematics of the scorpion Geographical distribution of scorpions in Morocco Dr Oulaid TOULOUN University of Science, Marrakech Session 2: Epidemiological Aspects & Management of Envenomation 15h00 Epidemiological and management of scorpion and snake envenomations Pr Rachida SOULAYMANI-BENCHEINKH Centre Anti-Poison et de Pharmacovigilance, Morocco Clinical management of scorpion and snake envenomations Pr Said YOUNOUS CHU Marrakech 3

16h00 16h30 DAY 2 9h00 Management of snakebite envenomation: clinical investigation and Impact of the antivenom Dr Fabien TAEIB Institut Pasteur of Morocco Session 3: Venoms, Composition & Mode of Action Scorpion and snakes venoms: Composition, mode of action, pharmacological and physiopathology Dr Naoual OUKKACHE Pasteur Institute of Morocco Structural & functional diversities of bioactive scorpion & snake venom compounds Pr Balkiss BOUHAOUALA Institut Pasteur of Tunis Involvement of inflammatory response and oxidative stress in pathogenesis of scorpion envenomation: role of neurotoxins Pr Fatima LARABA- DJEBARI University of Science and Technology, Algiers Scorpion toxins to understand neuropathologies/ Interaction of scorpion toxins with the nervous system Pr Rym Ben Khalifa Pasteur Institute of Tunis 4

Session 4: Immunotherapy (Classic and Innovative Approaches) 16h00 Challenges in the development of antivenoms, past and future Dr Jorge Fernando PANIAGUA-SOLIS International consultant, expert in biological products development, Lausanne - Switzerland 16h30 Advances in specific treatment against scorpion envenomation: from immunotherapy towards vaccine Pr Fatima LARABA- DJEBARI University of Science and Technology, Algiers DAY 3 Session 4: Immunotherapy (Classic and Innovative Approaches) 09h00 Strategies for antivenom efficacy improvement: Nanobody generation and engineering Pr Balkiss BOUHAOUALA Institut Pasteur of Tunis The clinical validation and standardization of the antivenom Pr Walter GARCIA UBBELOHDE Laboratorios Silanes, Mexico Session 5: Venomics & Antivenomics 16h00 16h30 Structural & proteomic mass spectrometry Pr Juan J. CALVETE Instituto de Biomedicina de Valencia New approaches for venomics and antivenomics investigations Pr Juan J. CALVETE Instituto de Biomedicina de Valencia An introduction to venomics: combining genomics, proteomics and bioinformatics Dr Reto STÖCKLIN Atheris SA, Geneva 5

DAY 4 Session 5: Therapeutic potential of scorpion & snakes venom peptides 09h00 Integrative bioinformatic approach for venom gland transcriptome annotation Dr Dominique KOUA National Polytechnical Institute of Yamoussoukro Natural peptides to drugs: venomous animals as drug discoverers Dr Reto STÖCKLIN Atheris SA, Geneva 13h00 PRACTICE 1: 14h30 Breeding and milking of venomous animals Mr Vincent VAGNIERE Expert in breeding and milking, Lausanne Protein concentration, Venom activity, Gel Electrophoresis, Chromatographic techniques, Antivenom production, antivenoms titration, affinity determination, cross-recognition assays, ELISA test for the clinical validation Salma CHAKIR (ph.d); Myriam REZZAK (ph.d), Dr Fatima CHGOURY and Dr Naoual OUKKACHE Institut Pasteur of Morocco 16h30 SOCIAL ACTIVITIES 6

DAY 5 PRACTICE 2: 9h00: Strategies for the discovery of novel bioactive drug candidates in animal venoms Dr Reto STÖCKLIN & Dr Dominique KOUA 12h00 ROUND TABLE: Building capacities in translational venomics m ici, M j ch ll s fu isi pp tu iti s CLOSING CEREMONY & CERTIFICATE S DISTRIBUTION ORGANISING COMMITTEE Dr Naoual OUKKACHE Dr Balkiss BOUHAOUALA Dr Reto STÖCKLIN 7